🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsDosing & ProtocolsMicro-dosing semaglutide — 12 month update

Micro-dosing semaglutide — 12 month update

FDA_TrackerJim Tue, Jan 20, 2026 at 10:57 AM 17 replies 874 viewsPage 1 of 4
FDA_TrackerJim
Senior Member
1,567
7,890
Feb 2024
Rockville, MD
Jan 20, 2026 at 12:22 PM#1

I've been reading about people micro-dosing semaglutide — taking doses like 0.125mg or even 0.1mg per week, below the standard starting dose of 0.25mg. The reasoning seems to be: minimize side effects, still get some appetite suppression, and potentially stay on the medication longer at a lower cost.

I'm particularly interested because I'm very petite (5'1", 140 lbs, BMI 26.4) and I don't need to lose a huge amount of weight. I'm worried that 0.25mg will be too aggressive for my size.

Has anyone tried this approach? Is there actual data on sub-therapeutic doses, or is this purely anecdotal?

48 24Dr.Martinez, mike_mod, SarahChen_PharmD and 45 others
Reply Quote Save Share Report
NicoleRaleigh
Member
356
1,567
Aug 2024
Raleigh, NC
Jan 20, 2026 at 12:39 PM#2

Interesting question and an area where the data is limited but the clinical logic isn't unreasonable.

First, the labeled titration starts at 0.25mg for 4 weeks — but this dose is explicitly described in the prescribing information as a "dose-initiation" dose, not intended to be therapeutic for weight loss. It's meant to acclimate your GI system. The therapeutic dose for weight loss starts at 0.5mg and goes up to 2.4mg.

That said, many patients report meaningful appetite suppression even at 0.25mg, and some providers are prescribing below that for exactly your scenario — smaller patients with less weight to lose.

The pharmacology supports some effect at low doses. GLP-1 receptor binding follows a dose-response curve, and even low receptor occupancy will produce some downstream effects including delayed gastric emptying and central appetite modulation. Whether it produces clinically meaningful weight loss at 0.1mg is genuinely unclear — it wasn't studied in the STEP trials.

My take: it's reasonable to discuss with your provider, especially given your stats. But don't expect the same magnitude of results.

[1] Wilding JPH, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1)." N Engl J Med. 2021;384(11):989-1002.

7 17MikeFit_NJ, InsuranceTom, WendyG_ATL and 4 others
Reply Quote Save Share Report
kevin_tulsa
Member
489
2,123
Jun 2024
Tulsa, OK
Jan 20, 2026 at 12:56 PM#3

I'm 5'0" and started at 0.125mg! My compounding pharmacy actually suggested it because of my size. I did 0.125mg for 6 weeks, then 0.25mg for 4 weeks, then 0.5mg where I've been for 3 months now.

Results at 0.125mg: lost 3 lbs over 6 weeks. Minimal nausea. Definitely noticed reduced appetite but it was subtle — like I just wasn't thinking about food as much. At 0.5mg the appetite suppression is much more obvious but the 0.125mg eased me in beautifully.

Given your stats (similar to mine starting out), I think a gentle start makes a lot of sense. You don't need to slam your system with the standard protocol designed for someone who weighs 250 lbs. 🤷‍♀️

37 7greg_boulder, quinn_sf, NurseLeah_Nash and 34 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
DoseLogDan
Member
201
567
Feb 2025
Montana
Jan 20, 2026 at 1:13 PM#4
Previously posted:
I think a gentle start makes a lot of sense. You don't need to slam your system with the standard protocol designed for someone who weighs 250 lbs.

I want to push back slightly on this framing. The 0.25mg starting dose in the STEP trials was used across a wide BMI range (27–50+), and the incidence of serious GI adverse events was generally low across all weight categories. The titration schedule was designed to be tolerable for most people, not just larger individuals.

That said, pharmacokinetics do vary by body weight. Semaglutide is distributed in plasma volume which correlates with body weight, so a 140 lb person will have higher mg/kg exposure than a 250 lb person at the same absolute dose. This does provide some pharmacological rationale for lower starting doses in smaller individuals.

I'm not against micro-dosing, I just want to make sure we're being precise about why it might make sense rather than assuming the standard protocol is "too aggressive."

[1] Lingvay I, et al. "Semaglutide for the Treatment of Obesity." Drugs. 2023;83(2):93-112.

Last edited: Jan 20, 2026 at 2:13 PM
25 10sophie_paris, mel_PDX, Dr.AddMedPHL and 22 others
Reply Quote Save Share Report
hannah_MT
New Member
23
89
Feb 2026
Bozeman, MT
Jan 20, 2026 at 1:30 PM#5

These are all really helpful perspectives. The mg/kg point is exactly what I was trying to articulate — I'm not saying 0.25mg is dangerous for smaller people, just that the relative exposure is higher for me than for someone twice my weight. That seems like a valid reason to consider starting lower.

I think I'll talk to my provider about starting at 0.125mg. If it does nothing after a month, I can always go to 0.25mg. 😊

32 12SleepFixSam, PurityPaulOR, MaxMetOK and 29 others
Reply Quote Save Share Report

Similar Threads

Micro-dosing semaglutide — is sub-therapeutic dosing effective?16 replies
Injection technique: subcutaneous depot formation and absorption8 replies
Semaglutide PK modeling — when to time your injection12 replies
Reconstitution calculator — compounded peptide dosing math7 replies
Half-life implications for missed doses — PK-based guidance5 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register